Skip to content
Clinical Trials – home

Botulinum Toxin Type A: A Comprehensive Guide for Patients

17 / 28
trials open to patients / all trials
13+
Countries

In short

Botulinum Toxin Type A, a powerful neurotoxin, is being studied in various clinical trials for its potential therapeutic benefits beyond its well-known cosmetic uses. These trials are exploring its effectiveness in treating conditions such as muscle spasticity, excessive tearing, facial spasms, and even scar prevention. This article summarizes key findings from recent clinical trials investigating new applications of Botulinum Toxin Type A injections.

What is Botulinum Toxin Type A?

Botulinum Toxin Type A, often referred to as BoNT-A or BTX-A, is a medical treatment derived from the bacterium Clostridium botulinum. While this bacterium is known to produce one of the most potent biological toxins, scientists have harnessed its properties for therapeutic use. Botulinum Toxin Type A is a protein that, when used in controlled medical settings, can provide relief for various conditions affecting muscles and nerves.

Medical Uses of Botulinum Toxin Type A

Botulinum Toxin Type A has a wide range of medical applications, including:

  • Spasticity: It's used to treat muscle stiffness and uncontrollable muscle contractions in conditions such as:
    • Post-stroke spasticity
    • Cerebral palsy
    • Multiple sclerosis
    • Spinal cord injuries
    • Traumatic brain injuries
  • Movement Disorders:
    • Cervical dystonia (also known as spasmodic torticollis), a condition causing involuntary neck muscle contractions
    • Hemifacial spasm, which causes involuntary muscle contractions on one side of the face
  • Pain Conditions:
    • Chronic neuropathic pain, which is pain caused by nerve damage
  • Cosmetic Uses:
    • Reduction of facial wrinkles, particularly in the forehead area
  • Other Conditions:
    • Temporomandibular joint (TMJ) dislocation, a problem with the jaw joint

How Botulinum Toxin Type A Works

Botulinum Toxin Type A works by temporarily paralyzing muscles. It does this by blocking the release of a chemical called acetylcholine at the junction between nerves and muscles. Acetylcholine is responsible for triggering muscle contractions. By preventing its release, Botulinum Toxin A causes the targeted muscles to relax.

In the case of pain conditions, Botulinum Toxin A is thought to work by blocking pain signals in addition to its muscle-relaxing effects.

How Botulinum Toxin Type A is Administered

Botulinum Toxin Type A is typically administered through injections directly into the affected muscles. The specific injection sites and doses depend on the condition being treated. For example:

  • For upper limb spasticity, injections may be given in the muscles of the elbow, wrist, fingers, and thumb.
  • For cervical dystonia, injections are given in the neck muscles.
  • For cosmetic purposes, injections are typically given in the forehead muscles.

The effects of Botulinum Toxin A are not permanent. Depending on the condition and individual response, treatments may need to be repeated every few months.

Effectiveness of Botulinum Toxin Type A

Clinical trials have shown Botulinum Toxin Type A to be effective for various conditions:

  • For post-stroke upper limb spasticity, it has been shown to reduce muscle tone and improve function.
  • In cervical dystonia, it can reduce the severity of abnormal head position and neck pain.
  • For hemifacial spasm, it can improve facial symmetry and reduce involuntary muscle contractions.
  • In the treatment of chronic neuropathic pain, it has shown promise in reducing pain intensity.

Potential Side Effects

While Botulinum Toxin Type A is generally considered safe when administered by trained healthcare professionals, it can have some side effects. These may include:

  • Temporary weakness in the injected muscles
  • Pain or bruising at the injection site
  • In facial treatments, there may be temporary drooping of the eyelid or asymmetry of facial expressions
  • In rare cases, the toxin's effects may spread to other parts of the body, causing more widespread muscle weakness

It's important to discuss potential side effects with your healthcare provider before starting treatment.

Brand Names and Formulations

Botulinum Toxin Type A is available under several brand names, including:

  • Botox
  • Dysport
  • Xeomin
  • Neuronox (also known as Meditoxin or Siax)

While these products all contain Botulinum Toxin Type A, they may have slight differences in formulation and dosing. Your healthcare provider will determine which formulation is most appropriate for your specific condition.

Questions people often ask

Conditions where Botulinum Toxin Type A is being studied

Each condition opens its own overview and trial list

Trials with Botulinum Toxin Type A

Recruiting trials first

See all 28 →
Quick filters
  • Participants:Adults
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.